[1]
J. Saragih, I. Saputra, M. Mawarpury, and E. M. Rahayuningsih, “Association of BDNF Val66Met polymorphism with clinical severity, cognitive function, and treatment response in schizophrenia”, Narra X, vol. 4, no. 2, p. e300, Jul. 2026.